Skip to main content
Equibles

Mark Schoenberg

Analyst

Equibles does not estimate personal net worth.

About Mark Schoenberg

Mark Schoenberg has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for UroGen Pharma Ltd. on May 19, 2026. The companies whose calls Mark Schoenberg spoke on are classified in the Healthcare sector.

Mark Schoenberg on recent calls

“Oh well thanks so the proprietary technology RT gel is a mixture of inert polymers proprietary mixture that when when cooled, forms a liquid, so it's sort of counter-intuitive.”
HC Wainwright 4th Annual BioConnect Investor Conference ·
“So I think what we learned at the AUA, and I think this comes through in the panel discussion with the KOLs that we did on that Sunday, is that now the Zesturi is out there and now people are beginning to understand how it works. and coupled with the durability data that were recently released showing 65% durability…”
UroGen Pharma Ltd. Q2 FY2025 Earnings Call ·

Company network

Recent activity